These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11263338

  • 1. [Report of 18 cases lymphoblastic lymphoma].
    Zhang X, Lu Z, Feng X.
    Zhonghua Xue Ye Xue Za Zhi; 1998 Nov; 19(11):566-8. PubMed ID: 11263338
    [Abstract] [Full Text] [Related]

  • 2. B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology.
    Soslow RA, Baergen RN, Warnke RA.
    Cancer; 1999 Jun 15; 85(12):2648-54. PubMed ID: 10375114
    [Abstract] [Full Text] [Related]

  • 3. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
    Pan Y, Li GD, Liu WP, Zhang WY, Tang Y, Li FY.
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec 15; 38(12):810-5. PubMed ID: 20193455
    [Abstract] [Full Text] [Related]

  • 4. T-cell lymphoblastic lymphoma and T-cell acute lymphoblastic leukemia: a separate entity?
    Hoelzer D, Gökbuget N.
    Clin Lymphoma Myeloma; 2009 Dec 15; 9 Suppl 3():S214-21. PubMed ID: 19778844
    [Abstract] [Full Text] [Related]

  • 5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr 15; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas.
    Yeh KH, Cheng AL, Su IJ, Lin MT, Tien HF, Shen MC, Wang CH, Chen YC.
    Anticancer Res; 1997 Apr 15; 17(3C):2269-72. PubMed ID: 9216700
    [Abstract] [Full Text] [Related]

  • 7. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B, Reiter A, Landmann E, Lang P, Lassay L, Dickerhoff R, Lakomek M, Henze G, von Stackelberg A.
    J Clin Oncol; 2009 Jul 10; 27(20):3363-9. PubMed ID: 19433688
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology.
    Haematologica; 2002 Feb 10; 87(2):154-66. PubMed ID: 11836166
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor G and D gene rearrangements.
    Gameiro P, Mortuza FY, Hoffbrand AV, Foroni L.
    Haematologica; 2002 Nov 10; 87(11):1126-34. PubMed ID: 12414341
    [Abstract] [Full Text] [Related]

  • 12. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK, Zhou Y, Hancock ML, Gajjar A, Rubnitz J, Ribeiro RC, Sandlund JT, Hudson M, Relling M, Evans WE, Pui CH.
    Cancer; 2005 Jan 15; 103(2):368-76. PubMed ID: 15599932
    [Abstract] [Full Text] [Related]

  • 13. [Survival outcomes of T-cell non-Hodgkin's lymphoma: a report of 111 cases].
    Huang Y, Lin TY, Wu QL, Su ZL, Huang HQ, Xia ZJ, Sun XF, Jiang WQ, Guan ZZ.
    Ai Zheng; 2005 Apr 15; 24(4):470-4. PubMed ID: 15820072
    [Abstract] [Full Text] [Related]

  • 14. Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience.
    Thomas X, Olteanu N, Charrin C, Lhéritier V, Magaud JP, Fiere D.
    Am J Hematol; 2001 Jun 15; 67(2):73-83. PubMed ID: 11343378
    [Abstract] [Full Text] [Related]

  • 15. Outcome of adult T-lymphoblastic lymphoma after acute lymphoblastic leukemia-type treatment: a GOELAMS trial.
    Hunault M, Truchan-Graczyk M, Caillot D, Harousseau JL, Bologna S, Himberlin C, Guyotat D, Berthou C, Casassus P, Baranger L, Béné MC, Ifrah N, Gyan E, GOELAMS Group.
    Haematologica; 2007 Dec 15; 92(12):1623-30. PubMed ID: 18055985
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. T cell receptor genotyping and HOXA/TLX1 expression define three T lymphoblastic lymphoma subsets which might affect clinical outcome.
    Baleydier F, Decouvelaere AV, Bergeron J, Gaulard P, Canioni D, Bertrand Y, Lepretre S, Petit B, Dombret H, Beldjord K, Molina T, Asnafi V, Macintyre E.
    Clin Cancer Res; 2008 Feb 01; 14(3):692-700. PubMed ID: 18245528
    [Abstract] [Full Text] [Related]

  • 18. [Factors of an unfavorable prognosis in patients with B-cell chronic lymphoid leukemia: a retrospective analysis of 206 cases].
    Nikitin EA, Lorie IuIu, Melikian AL, Samoĭlova RS, Bulycheva TI, Obukhova TN, Kaplanskaia IB, Doronin VA, Kolosova LIu, Goriacheva SR.
    Ter Arkh; 2003 Feb 01; 75(7):38-47. PubMed ID: 12934480
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
    Salzburg J, Burkhardt B, Zimmermann M, Wachowski O, Woessmann W, Oschlies I, Klapper W, Wacker HH, Ludwig WD, Niggli F, Mann G, Gadner H, Riehm H, Schrappe M, Reiter A.
    J Clin Oncol; 2007 Sep 01; 25(25):3915-22. PubMed ID: 17761975
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.